Anti-NR5A2 antibody produced in rabbit

Nuclear receptor subfamily 5, group A, member 2 (NR5A2) belongs to the family of nuclear receptors that function as regulatory transcription factors. It is related to SF-1/NR5A1 (mammalian steriodogenic factor-1), which regulates the development and functioning of adrenal glands and testis. NR5A2 is expressed in pancreas, liver and intestine, in adults. It is also expressed in breast adipose tissue and ovary. This protein was initially classified as an orphan nuclear receptor, but studies have shown that natural phospholipids, such as phosphatidylcholine or phosphatidylinositol are capable of binding to NR5A2.

Orphan nuclear receptor NR5A2 recombinant protein epitope signature tag (PrEST)

Anti-NR5A2 antibody produced in rabbit, a Prestige Antibody, is developed and validated by the Human Protein Atlas (HPA) project . Each antibody is tested by immunohistochemistry against hundreds of normal and disease tissues. These images can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. The antibodies are also tested using immunofluorescence and western blotting. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.

Nuclear receptor subfamily 5, group A, member 2 (NR5A2) modulates embryonic development, lipid homeostasis, reproduction and energy metabolism, by regulating the expression of genes involved in these processes. It maintains pluripotency in undifferentiated embryonic stem cells by controlling Oct4 expression. In liver, pancreas and intestine, NR5A2 maintains bile acid and cholesterol homeostasis by regulating the expressions of the involved proteins. It also maintains the production of pancreatic enzymes. In ovary and breast adipose tissue, it modulates the biosynthesis of steroids. Various malignancies, such as breast, endometrial, intestinal and pancreatic cancer are linked to abnormalities in NR5A2 expression. It also plays a key role in sustaining estrogen biosynthesis and signaling in ER+ (estrogen receptor) breast cancer. In postmenopausal women, this protein regulates the expression of genes in osteoblasts, and thus, might be linked to osteoporosis.

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Corresponding Antigen APREST70746.

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.